• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

驱动通路的多背景建模揭示了23种癌症类型中的共同和特定机制。

Multi-context modeling of driver pathways reveals common and specific mechanisms across 23 cancer types.

作者信息

Zhou Wenjia, Zhang Junhua

机构信息

CEMS, NCMIS, RCSDS, Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China.

School of Mathematical Sciences, University of Chinese Academy of Sciences, Beijing, China.

出版信息

PLoS Comput Biol. 2025 Aug 6;21(8):e1013349. doi: 10.1371/journal.pcbi.1013349. eCollection 2025 Aug.

DOI:10.1371/journal.pcbi.1013349
PMID:40768543
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12349879/
Abstract

Discovery of cancer driver pathways is essential for targeted therapies, since these pathways govern tumor progression and treatment resistance. However, their context-specific patterns across populations remain poorly understood. Leveraging pan-cancer genomic data, we apply our two models, EntCDP and ModSDP, to perform stratified analyses from four perspectives: region, tumor type, age group, and risk factors. Our results reveal the regional biases in perturbed pathways, such as PI3K-Akt in Chinese patients and GPCR in American patients with bladder cancer. Subtype comparisons highlight the mTOR signaling in lung adenocarcinoma and the FoxO signaling in lung squamous cell carcinoma. Pediatric-adult comparisons emphasize the enrichment of Ras signaling in pediatric acute myeloid leukemia and PAK signaling in pediatric glioblastoma, respectively. Risk factor associations further link Notch-mediated pathways to alcohol consumption and CDKN-regulated pathways to obesity-related cancers. Our findings demonstrate the utility of stratified driver pathway analysis in uncovering common and specific mechanisms, which can help prioritize context-aware therapeutic targets.

摘要

发现癌症驱动通路对于靶向治疗至关重要,因为这些通路控制着肿瘤进展和治疗抗性。然而,它们在不同人群中的特定背景模式仍知之甚少。利用泛癌基因组数据,我们应用我们的两种模型EntCDP和ModSDP,从四个角度进行分层分析:地区、肿瘤类型、年龄组和风险因素。我们的结果揭示了受干扰通路中的区域偏差,例如中国膀胱癌患者中的PI3K-Akt通路和美国膀胱癌患者中的GPCR通路。亚型比较突出了肺腺癌中的mTOR信号传导和肺鳞状细胞癌中的FoxO信号传导。儿童与成人的比较分别强调了Ras信号传导在儿童急性髓细胞白血病中的富集以及PAK信号传导在儿童胶质母细胞瘤中的富集。风险因素关联进一步将Notch介导的通路与饮酒联系起来,并将CDKN调节的通路与肥胖相关癌症联系起来。我们的研究结果证明了分层驱动通路分析在揭示共同和特定机制方面的实用性,这有助于确定上下文感知治疗靶点的优先级。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/457e1e7a9258/pcbi.1013349.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/8a5978107630/pcbi.1013349.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/8cd872a5d5e0/pcbi.1013349.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/ec7d7fb8202d/pcbi.1013349.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/5cbc70f880a7/pcbi.1013349.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/457e1e7a9258/pcbi.1013349.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/8a5978107630/pcbi.1013349.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/8cd872a5d5e0/pcbi.1013349.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/ec7d7fb8202d/pcbi.1013349.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/5cbc70f880a7/pcbi.1013349.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2c17/12349879/457e1e7a9258/pcbi.1013349.g005.jpg

相似文献

1
Multi-context modeling of driver pathways reveals common and specific mechanisms across 23 cancer types.驱动通路的多背景建模揭示了23种癌症类型中的共同和特定机制。
PLoS Comput Biol. 2025 Aug 6;21(8):e1013349. doi: 10.1371/journal.pcbi.1013349. eCollection 2025 Aug.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Interplay between tumor mutation burden and the tumor microenvironment predicts the prognosis of pan-cancer anti-PD-1/PD-L1 therapy.肿瘤突变负荷与肿瘤微环境之间的相互作用可预测泛癌抗PD-1/PD-L1治疗的预后。
Front Immunol. 2025 Jul 24;16:1557461. doi: 10.3389/fimmu.2025.1557461. eCollection 2025.
4
Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogramming.骨髓源性转移性神经母细胞瘤的单细胞与转录组学整合分析揭示代谢重编程的分子机制。
Sci Rep. 2025 Aug 5;15(1):28519. doi: 10.1038/s41598-025-13626-8.
5
The landscape of long non-coding RNA during cSCC progression.皮肤鳞状细胞癌进展过程中长链非编码RNA的情况
Br J Dermatol. 2025 Mar 27. doi: 10.1093/bjd/ljaf108.
6
Sun protection for preventing basal cell and squamous cell skin cancers.预防基底细胞癌和鳞状细胞皮肤癌的防晒措施。
Cochrane Database Syst Rev. 2016 Jul 25;7(7):CD011161. doi: 10.1002/14651858.CD011161.pub2.
7
Survivor, family and professional experiences of psychosocial interventions for sexual abuse and violence: a qualitative evidence synthesis.性虐待和暴力的心理社会干预的幸存者、家庭和专业人员的经验:定性证据综合。
Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD013648. doi: 10.1002/14651858.CD013648.pub2.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Comparative Genomic Analysis of Key Oncogenic Pathways in Hepatocellular Carcinoma Among Diverse Populations.不同人群肝细胞癌关键致癌途径的比较基因组分析
Cancers (Basel). 2025 Apr 13;17(8):1309. doi: 10.3390/cancers17081309.
10
Prognostic impact of glucagon-like peptide-1 receptor (GLP1R) expression on cancer survival and its implications for GLP-1R agonist therapy: an integrative analysis across multiple tumor types.胰高血糖素样肽-1受体(GLP1R)表达对癌症生存的预后影响及其对GLP-1R激动剂治疗的意义:一项跨多种肿瘤类型的综合分析
Geroscience. 2025 Jan 8. doi: 10.1007/s11357-024-01494-5.

本文引用的文献

1
PHF6 suppresses self-renewal of leukemic stem cells in AML.PHF6 抑制 AML 中的白血病干细胞自我更新。
Leukemia. 2024 Sep;38(9):1938-1948. doi: 10.1038/s41375-024-02340-5. Epub 2024 Jul 14.
2
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition.KMT2D 缺失驱动肺鳞状细胞癌并对 RTK-RAS 抑制敏感。
Cancer Cell. 2023 Jan 9;41(1):88-105.e8. doi: 10.1016/j.ccell.2022.11.015. Epub 2022 Dec 15.
3
Targeting NFE2L2/KEAP1 Mutations in Advanced NSCLC With the TORC1/2 Inhibitor TAK-228.
针对晚期 NSCLC 中 NFE2L2/KEAP1 突变的 TORC1/2 抑制剂 TAK-228。
J Thorac Oncol. 2023 Apr;18(4):516-526. doi: 10.1016/j.jtho.2022.09.225. Epub 2022 Oct 12.
4
Oncogenic signaling pathway dysregulation landscape reveals the role of pathways at multiple omics levels in pan-cancer.致癌信号通路失调图谱揭示了多种组学水平的通路在泛癌中的作用。
Front Genet. 2022 Aug 17;13:916400. doi: 10.3389/fgene.2022.916400. eCollection 2022.
5
Insights into Nanomedicine for Head and Neck Cancer Diagnosis and Treatment.头颈部癌症诊断与治疗的纳米医学见解
Materials (Basel). 2022 Mar 11;15(6):2086. doi: 10.3390/ma15062086.
6
DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update).DAVID:一个用于基因列表功能富集分析和功能注释的网络服务器(2021 更新)。
Nucleic Acids Res. 2022 Jul 5;50(W1):W216-W221. doi: 10.1093/nar/gkac194.
7
Smoking-related cancer death among men and women in an ageing society (China 2020-2040): a population-based modelling study.老龄化社会中男性和女性与吸烟有关的癌症死亡人数(中国 2020-2040 年):基于人群的建模研究。
Tob Control. 2023 Mar;32(2):163-169. doi: 10.1136/tobaccocontrol-2020-056444. Epub 2021 Nov 1.
8
Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence.来自八个发病率不同国家的食管鳞癌中的突变特征。
Nat Genet. 2021 Nov;53(11):1553-1563. doi: 10.1038/s41588-021-00928-6. Epub 2021 Oct 18.
9
Genomic and evolutionary classification of lung cancer in never smokers.非吸烟人群肺癌的基因组和进化分类。
Nat Genet. 2021 Sep;53(9):1348-1359. doi: 10.1038/s41588-021-00920-0. Epub 2021 Sep 6.
10
-Regulated Transcriptome and Its Therapeutic Significance in Ovarian Cancer.-卵巢癌中的调控转录组及其治疗意义。
Biomolecules. 2021 Aug 14;11(8):1211. doi: 10.3390/biom11081211.